Table 2.
Clinical characteristics of the study patients
| Parameters | In-stent restenosis (n = 22) | Control (n = 42) | p value |
|---|---|---|---|
| Age (years; mean ± SD) | 69 ± 7 | 63 ± 10 | 0.012 |
| Male (%) | 46 | 57 | 0.37 |
| Diabetes mellitus (%) | 46 | 31 | 0.25 |
| Hypercholesterolemia (%) | 36 | 43 | 0.62 |
| Smoking (%) | 14 | 24 | 0.36 |
| Nephropathy (%) | 0 | 3 | 0.45 |
| Treated hypertension (%) | 76 | 89 | 0.19 |
| Previous myocardial infarction (%) | 14 | 24 | 0.36 |
| Treated vessel (%) | 0.186 | ||
| LAD | 37 | 57 | |
| Cx | 27 | 12 | |
| RCA | 36 | 31 | |
| Stent type (%) | 0.99 | ||
| BMS | 46 | 45 | |
| DES | 54 | 55 |
As an index of statistical significance, a p value < 0.05 was accepted and marked bold
LAD left anterior descending, Cx left circumflex, RCA right coronary artery, BMS bare metal stent, DES drug-eluting stent